Fourth quarter Adjusted
EBITDA1 of $428 million and full year
Adjusted EBITDA of $1,690
million
Fourth quarter and full year net earnings per
share of $0.73 and $2.68,
respectively
Annualized dividend increasing by $0.04 per share (3 percent) to $1.44 per share
CALGARY,
AB, March 5, 2025 /CNW/ - Parkland Corporation
("Parkland", "we", the "Company", or "our") (TSX:PKI), today
announced its financial and operating results for the three months
and year ended December 31,
2024. The Company further announced that its Board of
Directors (the "Board") has initiated a review of strategic
alternatives (the "Strategic Review") to identify opportunities to
maximize value for all shareholders.

The Strategic Review will be led by a Special Committee of the
Board which is comprised solely of independent directors (the
"Special Committee"). During this process, the Company will analyze
and evaluate its business strategy and optimization opportunities,
while also considering value maximization alternatives which are in
the best interests of all shareholders. This may include, but is
not limited to, asset divestments, acquisitions, transformative
business combinations and a sale of the Company. Parkland has
engaged Goldman Sachs Canada Inc. and BofA Securities as its
financial advisors for the Strategic Review.
"Parkland's Board remains committed to acting in
the best interests of all shareholders," said Michael Jennings, Chair of Parkland's Board of
Directors. "While we are confident in the tremendous value creating
potential of our business, strategic plan, and management's ability
to execute, the current share price does not fully reflect the
intrinsic value of the Company. As a result, our Board believes the
Strategic Review is a necessary step to explore opportunities to
maximize value creation for all shareholders. We are openly
inviting Simpson Oil to rejoin the Company's Board and participate
on the Special Committee."
Parkland cautions that there are no guarantees that the
strategic review process will result in a transaction or if a
transaction is undertaken, as to its terms or timing. The Company
will continue to actively engage with its shareholders throughout
the process and provide periodic updates on its progress.
Fourth Quarter and Year-End 2024 Results
"As the Company initiates a Strategic Review, I
want to thank the Parkland team for their dedication in 2024 and
their continued focus on serving our customers. The team made great
progress executing our priorities and building a platform for
growth during the year," said Bob Espey, President and Chief
Executive Officer. "In 2024, our combined retail and commercial
businesses demonstrated resilience in a challenging environment.
While the Refinery and USA
segments fell short of our expectations, partly due to unfavourable
external market factors, our continued focus on operational
excellence and serving our customers, combined with higher expected
composite utilization of the Burnaby Refinery, gives me confidence
in our 2025 Guidance."
___________
|
(1)
|
Total of segments
measure. See "Measures of Segment Profit (Loss) and Total of
Segments Measures" section of this news release.
|
Q4 2024 Highlights
- Adjusted EBITDA of $428 million,
as compared to $463 million in Q4
2023. Resilient underlying performance in our combined retail and
commercial lines of business was more than offset by a lower
refining margin environment.
- Net loss of $29 million
($0.17 per share, basic), as compared
to net earnings of $86 million
($0.49 per share, basic) in Q4 2023,
and Adjusted earnings2 of $100
million ($0.58 per share,
basic2), as compared to $151
million ($0.86 per share,
basic) in Q4 2023.
- Canada delivered Adjusted
EBITDA of $190 million, as compared
to $190 million in Q4 2023. Stronger
fuel unit margins from continued price and supply optimization and
lower operating costs were offset by lower commercial volumes due
to unseasonably warm weather and the divestment of the commercial
propane business.
- International delivered Adjusted EBITDA of $171 million, as compared to $157 million in Q4 2023. Strong performance in
the retail business, particularly in Guyana and Suriname, and the marine business
were partially offset by the impact of lower wholesale
volumes.
- USA delivered Adjusted EBITDA
of $32 million, as compared to
$39 million in Q4 2023. The timing of
certain expenses and a challenging volume environment were
partially offset by stronger fuel unit margins.
- Refining delivered Adjusted EBITDA of $60 million, as compared to $106 million in Q4 2023. The decrease was
primarily driven by lower refining margins. Composite
utilization3 at the Burnaby Refinery was approximately
89 percent in Q4 2024, as compared to approximately 90 percent in
Q4 2023.
Full Year 2024 Highlights
- Adjusted EBITDA of $1,690
million, as compared to $1,913
million in 2023. Resilient performance in the combined
retail and commercial lines of business was more than offset by a
lower refining margin environment in the second half of 2024 and
the unplanned shutdown of the Burnaby Refinery in the first quarter
of 2024.
- Net earnings of $127 million
($0.73 per share, basic), as compared
to $471 million ($2.68 per share, basic) in 2023, and Adjusted
earnings of $405 million
($2.32 per share, basic) as compared
to $626 million in 2023 ($3.56 per share, basic).
- Available cash flow2 of $556
million ($3.19 per
share2), as compared to $812
million ($4.61 per share) in
2023. Cash generated from (used in) operating activities of
$1,535 million ($8.80 per share4) in 2024 as compared
to $1,780 million ($10.13 per share) in 2023. These decreases were
largely due to lower refinery segment results, restructuring
activities and the ongoing implementation of enterprise-wide
systems designed to improve operational efficiency, provide
long-term cost savings and support future growth.
- Year-end 2024 Liquidity available4 increased to
$2,045 million from $1,339 million at year-end 2023, reflecting the
senior unsecured note issuance used to repay a portion of the
outstanding drawings under the Company's credit facilities.
- Year-end 2024 Leverage Ratio5 was 3.6 times, as
compared to 2.8 times at year-end 2023. The increase reflects lower
2024 Adjusted EBITDA and unfavourable translation of
USD-denominated debt balances.
- Return on invested capital2 ("ROIC") was 7.4 percent
in 2024, as compared to 9.8 percent in 2023.
- Parkland delivered a strong safety performance in 2024, with a
total recordable injury frequency rate3 of 1.01,
approximately a 6 percent improvement from prior year.
- Canada Company same-store volume growth ("Company
SSVG")3 was 1.2 percent, demonstrating strength in our
company-owned network and benefits from our loyalty program.
- USA results fell below
expectations as unfavourable market conditions negatively impacted
industry volumes and margins, overshadowing Parkland's integration
and optimization efforts.
___________
|
(2)
|
Non-GAAP financial
measure or non-GAAP financial ratio. See "Non-GAAP Financial
Measures and Ratios" section of this news release.
|
(3)
|
Non-financial
measure. See "Non-Financial Measures" section of this news
release.
|
(4)
|
Supplementary financial
measure. See "Supplementary Financial Measures" section of this
news release.
|
(5)
|
Capital management
measure. See "Capital Management Measures" section of this news
release.
|
Enhancing Shareholder Returns
Parkland maintains a disciplined approach to capital allocation
designed to deliver sustainable dividend growth and capital
appreciation for long-term shareholders. The Company's
framework balances the need to maintain financial strength and
flexibility, fund Parkland's organic growth capital program and
return capital to shareholders.
Parkland's quarterly dividend will increase approximately 3
percent, from $0.35 to $0.36 per common share, effective with the
quarterly dividend payable on April 15,
2025, to shareholders of record at the close of business on
March 21, 2025.
In 2024, Parkland purchased and cancelled approximately 2.9
million common shares for $125
million under its normal course issuer bid program.
Consolidated Financial Overview
($ millions, unless
otherwise noted)
|
Three months
ended
December 31,
|
Year ended
December 31,
|
Financial
Summary
|
2024
|
2023
|
2024
|
2023
|
Sales and operating
revenue
|
6,734
|
7,746
|
28,303
|
32,452
|
Adjusted
EBITDA(1)
|
428
|
463
|
1,690
|
1,913
|
Canada(2)
|
190
|
190
|
753
|
713
|
International(2)
|
171
|
157
|
654
|
678
|
USA(2)
|
32
|
39
|
168
|
186
|
Refining(2)
|
60
|
106
|
198
|
441
|
Corporate(2)
|
(25)
|
(29)
|
(83)
|
(105)
|
Net earnings
(loss)
|
(29)
|
86
|
127
|
471
|
Net earnings (loss) per
share – basic ($ per share)
|
(0.17)
|
0.49
|
0.73
|
2.68
|
Net earnings (loss) per
share – diluted ($ per share)
|
(0.17)
|
0.48
|
0.72
|
2.63
|
Cash generated from
(used in) operating activities
|
462
|
417
|
1,535
|
1,780
|
Trailing-twelve-month
("TTM") Cash generated from (used in) operating activities per
share(3)
|
8.80
|
10.13
|
8.80
|
10.13
|
TTM Available cash
flow(4)
|
556
|
812
|
556
|
812
|
TTM Available cash flow
per share(4)
|
3.19
|
4.61
|
3.19
|
4.61
|
TTM ROIC
(4)
|
7.4 %
|
9.8 %
|
7.4 %
|
9.8 %
|
(1)
|
Total of segments
measure. See "Measures of Segment Profit (Loss) and Total of
Segments Measures" section of this news release.
|
(2)
|
Measure of
segment profit (loss). See "Measures of Segment Profit (Loss) and
Total of Segments Measures" section of this news
release.
|
(3)
|
Supplementary financial
measure. See "Supplementary Financial Measures" section of this
news release.
|
(4)
|
Non-GAAP financial
measure or non-GAAP financial ratio. See "Non-GAAP Financial
Measures and Ratios" section of this news release.
|
Q4 2024 Conference Call and Webcast
Details
Parkland will host a webcast and conference call on Thursday, March 6, 2025, at 6:30 am MT (8:30 am
ET) to discuss the results. To listen to the live webcast
and watch the presentation, please use the following link:
https://app.webinar.net/o5PNjYomM2w
Analysts and investors interested in participating in the
question and answer session of the conference call may do so by
calling 1-888-510-2154 (toll-free) (Conference ID: 19397).
International participants may call 1-437-900-0527, 1-800-389-0704
(toll-free) (Conference ID: 19397).
Please connect and log in approximately 10 minutes before the
beginning of the call. The webcast will be available for replay two
hours after the conference call ends at the link above. It will
remain available for one year and will also be posted at
www.parkland.ca.
MD&A and Annual Consolidated Financial Statements
The Management's Discussion and Analysis for the year ended
December 31, 2024 (the "Q4 2024
MD&A") and Annual Consolidated Financial Statements for the
year ended December 31, 2024 (the
"2024 Annual Consolidated Financial Statements") provide a detailed
explanation of Parkland's operating results for the year ended
December 31, 2024. An English version
of these documents will be available online at
www.parkland.ca and the System for Electronic Data Analysis
and Retrieval+ ("SEDAR+") after the results are released by
newswire under Parkland's profile at www.sedarplus.ca. The French
versions of the Q4 2024 MD&A and the 2024 Annual Consolidated
Financial Statements will be posted to www.parkland.ca and
SEDAR+ as soon as they become available.
About Parkland Corporation
Parkland is a leading international fuel distributor, marketer,
and convenience retailer with safe and reliable operations in 26
countries across the Americas. Our retail network meets the fuel
and convenience needs of everyday consumers. Our commercial
operations provide businesses with fuel to operate, complete
projects and better serve their customers. In addition to meeting
our customers' needs for essential fuels, Parkland provides a range
of choices to help them lower their environmental impact, including
manufacturing and blending renewable fuels, ultra-fast EV charging,
a variety of solutions for carbon credits and renewables, and solar
power. With approximately 4,000 retail and commercial locations
across Canada, the United States and the Caribbean region, we have developed supply,
distribution and trading capabilities to accelerate growth and
business performance.
Our strategy is focused on two interconnected pillars: our
Customer Advantage and our Supply Advantage. Through our Customer
Advantage, we aim to be the first choice of our customers through
our proprietary brands, differentiated offers, extensive network,
competitive pricing, reliable service, and compelling loyalty
program. Our Supply Advantage is based on achieving the lowest cost
to serve among independent fuel marketers and distributors in the
hard-to-serve markets in which we operate, through our
well-positioned assets, significant scale, and deep supply and
logistics capabilities. Our business is underpinned by our people
and our values of safety, integrity, community and respect, which
are embedded across our organization.
Forward-Looking Statements
Certain statements contained herein constitute forward-looking
information and statements (collectively, "forward-looking
statements"). When used the words "expect", "will", "could",
"would", "believe", "continue", "pursue" and similar expressions
are intended to identify forward-looking statements. In particular,
this news release contains forward-looking statements with respect
to, among other things: the Strategic Review, the process and
details relating thereto, including with respect to Parkland
considering value maximization alternatives and evaluating its
existing business strategies and optimization opportunities, and
the expectation resulting therefrom to maximize value for all
shareholders; the Board's commitment to Parkland shareholders and
the Board's beliefs with respect to Parkland's business, strategic
plan, management and current share price as well as the Strategic
Review and expectations relating thereto; business
strategies, objectives and initiatives; continued focus on
operational excellence and serving Parkland's customers;
expectations for composition utilization at the Burnaby Refinery;
confidence in Parkland's 2025 Guidance; Parkland's enterprise-wide
systems, the implementation thereof and expected benefits
therefrom; Parkland's disciplined capital allocation framework and
the impact thereof on shareholder returns, maintaining financial
strength and flexibility and funding Parkland's organic growth
capital program; and Parkland's expectations regarding future
dividend amounts and the timing and frequency of payments.
These statements involve known and unknown risks, uncertainties
and other factors that may cause actual results or events to differ
materially from those anticipated in such forward-looking
statements. No assurance can be given that these expectations will
prove to be correct and such forward-looking statements included in
this news release should not be unduly relied upon. These
forward-looking statements speak only as of the date of this news
release. Parkland does not undertake any obligation to publicly
update or revise any forward-looking statements except as required
by securities law. Actual results could differ materially from
those anticipated in these forward-looking statements as a result
of numerous risks and uncertainties including, but not limited to:
the Strategic Review process and the timing thereof, whether the
Strategic Review will result in Parkland undertaking a transaction,
and if so, the terms and timing relating thereto, the completion
thereof and realizing benefits resulting therefrom; general
economic, market and business conditions; micro
and macroeconomic trends and conditions, including increases
in interest rates, inflation, imposition of tariffs and fluctuating
commodity prices; Parkland's ability to execute its business
objectives, projects and strategies, including the completion,
financing and timing thereof, realizing the benefits therefrom and
meeting our targets and commitments relating thereto; the
operations of the Burnaby Refinery, including continuing to operate
as expected and the ability of suppliers to meet commitments;
Parkland's ability to meet its 2025 Guidance and the assumptions
relating thereto; Parkland's ability to execute on its disciplined
capital allocation framework; Parkland's ability to pay future
dividends; and other factors, many of which are beyond the control
of Parkland and the assumptions and risks described in "Cautionary
Statement Regarding Forward-Looking Information" and "Risk Factors"
included in Parkland's most recently filed Annual Information Form,
and in "Forward-Looking Information" and "Risk Factors" in the Q4
2024 MD&A, each as filed on SEDAR+ and available on the
Parkland website at www.parkland.ca. The forward-looking statements
contained in this news release as expressly qualified by these
cautionary statements.
Specified Financial Measures
This news release contains total of segments measures, non-GAAP
financial measures and non-GAAP financial ratios, supplementary
financial measures and capital management measures (collectively,
"specified financial measures"). Parkland's management uses certain
specified financial measures to analyze the operating and financial
performance, leverage, and liquidity of the business. These
specified financial measures do not have any standardized meaning
under International Financial Reporting Standards as issued by the
International Accounting Standards Board ("IFRS Accounting
Standards") and are therefore unlikely to be comparable to similar
measures presented by other companies. The specified financial
measures should not be considered in isolation or used in
substitute for measures of performance prepared in accordance with
the IFRS Accounting Standards. See
Section 16 of the Q4 2024 MD&A, which is incorporated by
reference into this news release, for further details regarding
specified financial measures used by Parkland.
Non-GAAP Financial Measures and Ratios
Adjusted earnings (loss) is a non-GAAP financial measure and
Adjusted earnings (loss) per share is a non-GAAP financial ratio,
each representing the underlying core operating performance of
business activities of Parkland at a consolidated level. The most
directly comparable financial measure to Adjusted earnings (loss)
and Adjusted earnings (loss) per share is Net earnings (loss).
Adjusted earnings (loss) and Adjusted earnings (loss) per share
represent how well Parkland's operational business is performing,
while considering depreciation and amortization, interest on leases
and long-term debt, accretion and other finance costs, and income
taxes. The Company uses these measures because it believes that
Adjusted earnings (loss) and Adjusted earnings (loss) per share are
useful for management and investors in assessing the Company's
overall performance, as they exclude certain items that are not
reflective of the Company's underlying business operations.
See Section 16 of the Q4 2024
MD&A, which is incorporated by reference into this news
release, for the detailed definition and composition of Adjusted
earnings (loss) and Adjusted earnings (loss) per share.
Please see below for the reconciliation of Adjusted earnings
(loss) to net earnings (loss) and the calculation of Adjusted
earnings (loss) per share.
|
Three months
ended
December 31,
|
Year ended
December 31,
|
($ millions, unless
otherwise stated)
|
2024
|
2023
|
2024
|
2023
|
Net earnings
(loss)
|
(29)
|
86
|
127
|
471
|
Add:
|
|
|
|
|
Acquisition,
integration and other costs
|
81
|
42
|
218
|
146
|
(Gain) loss on foreign
exchange – unrealized
|
(2)
|
—
|
6
|
35
|
(Gain) loss on risk
management and other – unrealized
|
34
|
28
|
45
|
(34)
|
Other (gains) and
losses
|
30
|
5
|
38
|
3
|
Other adjusting
items(1)
|
20
|
6
|
53
|
48
|
Tax
normalization(2)
|
(34)
|
(16)
|
(82)
|
(43)
|
Adjusted earnings
(loss)
|
100
|
151
|
405
|
626
|
Weighted average number
of common shares (million shares)(3)
|
174
|
176
|
174
|
176
|
Weighted average number
of common shares adjusted for the effects of dilution (million
shares)(3)
|
174
|
180
|
177
|
179
|
Adjusted earnings
(loss) per share ($ per share)
|
|
|
|
|
Basic
|
0.58
|
0.86
|
2.32
|
3.56
|
Diluted
|
0.57
|
0.84
|
2.29
|
3.50
|
(1)
|
Other adjusting items
for the three months ended December 31, 2024 include: (i) the share
of depreciation, income taxes and other adjustments for investments
in joint ventures and associates of $18 million (2023 - $9
million); (ii) the impact of hyperinflation accounting of $4
million (2023 - $2 million); (iii) other income of $1 million (2023
- $2 million); (iv) realized gains and losses on risk management
and other assets and liabilities related to underlying physical
sales activity in another period of $1 million gain (2023 - $2
million); (v) adjustment to foreign exchange losses related to cash
pooling arrangements of $1 million gain (2023 - $1 million); and
(vi) adjustment to realized risk management gains related to
interest rate swaps, as these gains do not relate to commodity sale
and purchase transactions, of $1 million (2023 - nil). Other
adjusting items for the year ended December 31, 2024 include: (i)
the share of depreciation, income taxes and other adjustments for
investments in joint ventures and associates of $29 million (2023 -
$20 million); (ii) realized gains and losses on risk management and
other assets and liabilities related to underlying physical sales
activity in another period of $11 million loss (2023 - $6 million
gain); (iii) other income of $9 million (2023 -
$23 million); (iv) the impact of hyperinflation accounting of
$4 million (2023 - $2 million); (v) adjustment to foreign
exchange losses related to cash pooling arrangements of $3 million
(2023 - nil); (vi) adjustment to realized risk management
gains related to interest rate swaps, as these gains do not relate
to commodity sale and purchase transactions, of $3 million (2023 -
nil); and (vii) the effect of market-based performance conditions
for equity-settled share-based award settlements of nil (2023 - $13
million).
|
(2)
|
The tax normalization
adjustment was applied to net earnings (loss) adjusting items that
were considered temporary differences, such as acquisition,
integration and other costs, unrealized foreign exchange gains and
losses, unrealized gains and losses on risk management and other,
gains and losses on asset disposals, changes in fair value of
redemption options, changes in estimates of environmental
provisions, loss on inventory write-downs for which there are
offsetting associated risk management derivatives with unrealized
gains, impairments of non-current assets. The tax impact was
estimated using the effective tax rates applicable to jurisdictions
where the related items occur.
|
(3)
|
Weighted average number
of common shares are calculated in accordance with Parkland's
accounting policy contained in Note 2 of the 2024 Annual
Consolidated Financial Statements.
|
Available cash flow is a non-GAAP financial measure and
Available cash flow per share is a non-GAAP financial ratio. The
most directly comparable financial measure for Available cash flow
and Available cash flow per share is cash generated from (used in)
operating activities. Parkland uses these measures to monitor its
ability to generate cash flow for capital allocation, including
distributions to shareholders, investment in the growth of the
business, and deleveraging. See
Section 16 of the Q4 2024 MD&A, which is incorporated by
reference into this news release, for the detailed definition and
composition of Available cash flow and Available cash flow per
share. See the following table for a calculation of historical
Available cash flow and Available cash flow per share and a
reconciliation to cash generated from (used in) operating
activities.
|
Three months
ended
|
Trailing twelve
months ended
December 31,
2024
|
($ millions, unless
otherwise noted)
|
March 31,
2024 (1)
|
June 30,
2024
|
September 30,
2024
|
December 31,
2024
|
Cash generated from
(used in) operating activities
|
217
|
450
|
406
|
462
|
1,535
|
Reverse: Change in
other assets and other liabilities
|
28
|
3
|
(68)
|
80
|
43
|
Reverse: Net change in
non-cash working capital related to operating
activities(1)
|
55
|
(34)
|
21
|
(180)
|
(138)
|
Include: Maintenance
capital expenditures
|
(59)
|
(53)
|
(71)
|
(96)
|
(279)
|
Include: Dividends
received from investments in associates and joint
ventures
|
2
|
8
|
3
|
7
|
20
|
Include: Interest on
leases and long-term debt
|
(85)
|
(88)
|
(85)
|
(87)
|
(345)
|
Include: Payments of
principal amount on leases
|
(71)
|
(64)
|
(69)
|
(76)
|
(280)
|
Available cash
flow
|
87
|
222
|
137
|
110
|
556
|
Weighted average number
of common shares (millions)(2)
|
|
|
|
|
174
|
TTM Available cash flow
per share
|
|
|
|
|
3.19
|
|
Three months
ended
|
Trailing twelve
months ended
December 31,
2023
|
($ millions, unless
otherwise noted)
|
March 31,
2023
|
June 30,
2023(1)
|
September 30,
2023
|
December 31,
2023
|
Cash generated from
(used in) operating activities
|
314
|
521
|
528
|
417
|
1,780
|
Reverse: Change in
other assets and other liabilities
|
11
|
(11)
|
7
|
(4)
|
3
|
Reverse: Net change in
non-cash working capital related to operating
activities(1)
|
18
|
(145)
|
(14)
|
17
|
(124)
|
Include: Maintenance
capital expenditures
|
(79)
|
(61)
|
(52)
|
(93)
|
(285)
|
Include: Dividends
received from investments in associates and joint
ventures
|
16
|
2
|
4
|
3
|
25
|
Include: Interest on
leases and long-term debt
|
(92)
|
(89)
|
(83)
|
(88)
|
(352)
|
Include: Payments on
principal amount on leases
|
(51)
|
(56)
|
(57)
|
(71)
|
(235)
|
Available cash
flow
|
137
|
161
|
333
|
181
|
812
|
Weighted average number
of common shares (millions)(2)
|
|
|
|
|
176
|
TTM Available cash flow
per share
|
|
|
|
|
4.61
|
(1)
|
For comparative
purposes, certain amounts within the net change in non-cash working
capital related to operating activities for the three
months ended March 31, 2024, and the three months ended June
30, 2023, were revised to conform to the current period
presentation.
|
(2)
|
Weighted average number
of common shares is calculated in accordance with Parkland's
accounting policy contained in Note 2 of the 2024 Annual
Consolidated Financial Statements.
|
ROIC is a non-GAAP financial ratio. The measure is calculated as
a ratio of Net operating profit after tax ("NOPAT") divided by
average invested capital. NOPAT describes the profitability of
Parkland's base operations, excluding the impact of leverage and
certain other items of income and expenditure that are not
considered representative of Parkland's underlying core operating
performance. NOPAT is based on Adjusted EBITDA, defined in the
"Measures of Segment Profit (Loss) and Total of Segments Measures"
section of this news release, less depreciation and amortization
expense, including pro-forma depreciation on assets classified as
held for sale, and the estimated tax expense using the expected
average tax rate estimated using statutory tax rates in each
jurisdiction where Parkland operates. Average invested capital is
the amount of capital deployed by Parkland that represents the
average of opening and closing debt and shareholder's equity,
including equity reserves, net of cash and cash equivalents. We use
this non-GAAP measure to assess Parkland's efficiency in investing
capital.
($ millions, unless
otherwise noted)
|
Trailing twelve
months
ended December
31,
|
ROIC
|
2024
|
2023
|
Net earnings
(loss)
|
127
|
471
|
Add/(less):
|
|
|
Income tax expense
(recovery)
|
—
|
37
|
Acquisition,
integration and other costs
|
218
|
146
|
Depreciation and
amortization
|
825
|
823
|
Finance cost
|
378
|
384
|
(Gain) loss on foreign
exchange - unrealized
|
6
|
35
|
(Gain) loss on risk
management and other - unrealized
|
45
|
(34)
|
Other (gains) and
losses
|
38
|
3
|
Other adjusting
items
|
53
|
48
|
Adjusted
EBITDA
|
1,690
|
1,913
|
Less: Depreciation and
amortization
|
(825)
|
(823)
|
Less: Pro-forma
depreciation and amortization on assets classified as held for
sale
|
(7)
|
—
|
Adjusted
EBIT
|
858
|
1,090
|
Average effective tax
rate
|
19.5 %
|
16.7 %
|
Less: Taxes
|
(167)
|
(182)
|
Net operating profit
after tax
|
691
|
908
|
Opening invested
capital
|
9,152
|
9,293
|
Closing invested
capital
|
9,563
|
9,152
|
Average invested
capital
|
9,356
|
9,223
|
Return on invested
capital
|
7.4 %
|
9.8 %
|
Invested
Capital
|
December
31,
|
($ millions, unless
otherwise noted)
|
2024
|
2023
|
2022
|
Long-term debt -
current portion
|
261
|
191
|
173
|
Long-term
debt
|
6,380
|
6,167
|
6,799
|
Long-term debt in
liabilities classified as held for sale
|
141
|
—
|
—
|
Shareholders'
equity
|
3,166
|
3,181
|
3,037
|
Exclude: Cash and cash
equivalents
|
(385)
|
(387)
|
(716)
|
Total
|
9,563
|
9,152
|
9,293
|
These non-GAAP financial measures and ratios should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS Accounting Standards.
Except as otherwise indicated, these non-GAAP financial measures
and ratios are calculated and disclosed on a consistent basis from
period to period. See Section 16 of
the Q4 2024 MD&A, which is incorporated by reference into this
news release, for further details regarding Parkland's non-GAAP
financial measures and ratios.
Capital Management Measures
Parkland's primary capital management measure is the Leverage
Ratio, which is used internally by key management personnel to
monitor Parkland's overall financial strength, capital structure
flexibility, and ability to service debt and meet current and
future commitments. In order to manage its financing requirements,
Parkland may adjust capital spending or dividends paid to
shareholders, or issue new shares or new debt. The Leverage Ratio
is calculated as a ratio of Leverage Debt to Leverage EBITDA and
does not have any standardized meaning prescribed under IFRS
Accounting Standards. It is, therefore, unlikely to be comparable
to similar measures presented by other companies. The detailed
calculation of the Leverage Ratio is as follows:
($ millions, unless
otherwise noted)
|
December 31,
2024
|
December 31,
2023
|
Leverage
Debt
|
5,268
|
4,976
|
Leverage
EBITDA
|
1,481
|
1,780
|
Leverage
Ratio
|
3.6
|
2.8
|
($ millions, unless
otherwise noted)
|
December 31,
2024
|
December 31,
2023
|
Long-term
debt
|
6,641
|
6,358
|
Less:
|
|
|
Lease
obligations
|
(1,054)
|
(1,048)
|
Cash and cash
equivalents
|
(385)
|
(387)
|
Non-recourse
debt(1)
|
(30)
|
—
|
Risk management
asset(2)
|
(30)
|
—
|
Add:
|
|
|
Non-recourse
cash(1)
|
31
|
—
|
Letters of credit and
other
|
95
|
53
|
Leverage
Debt
|
5,268
|
4,976
|
(1)
|
Represents non-recourse
debt and non-recourse cash balance related to project
financing.
|
(2)
|
Represents the risk
management asset/liability associated with the spot element of the
cross-currency swap designated in a cash flow
hedge relationship to hedge the variability of principal cash
flows of the 2024 Senior Notes resulting from changes in the spot
exchange rates.
|
|
Three months
ended
|
Trailing twelve
months ended
December 31,
2024
|
($ millions, unless
otherwise noted)
|
March 31,
2024
|
June 30,
2024
|
Sept 30,
2024
|
December 31,
2024
|
Adjusted
EBITDA
|
327
|
504
|
431
|
428
|
1,690
|
Share incentive
compensation
|
6
|
8
|
6
|
11
|
31
|
Reverse: IFRS 16
impact(1)
|
(83)
|
(80)
|
(84)
|
(91)
|
(338)
|
|
250
|
432
|
353
|
348
|
1,383
|
Acquisition pro-forma
adjustment(2)
|
|
|
|
|
11
|
Other
adjustments(3)
|
|
|
|
|
87
|
Leverage
EBITDA
|
|
|
|
|
1,481
|
(1)
|
Includes the impact of
operating leases prior to the adoption of IFRS 16, previously
recognized under operating costs, which aligns with
management's view of the impact of earnings.
|
(2)
|
Includes the impact of
pro-forma pre-acquisition EBITDA estimates based on anticipated
benefits, costs and systems from acquisitions.
|
(3)
|
Includes adjustments to
normalize Adjusted EBITDA for non-recurring events relating to the
unplanned shutdowns at the Burnaby Refinery and the EBITDA
attributable to EV charging operations financed through
non-recourse project financing.
|
|
Three months
ended
|
Trailing twelve
months ended
December 31, 2023
|
($ millions, unless
otherwise noted)
|
March 31,
2023
|
June 30,
2023
|
September 30,
2023
|
December 31,
2023
|
Adjusted
EBITDA
|
395
|
470
|
585
|
463
|
1,913
|
Share incentive
compensation
|
8
|
6
|
5
|
11
|
30
|
Reverse: IFRS 16
impact(1)
|
(61)
|
(68)
|
(71)
|
(82)
|
(282)
|
|
342
|
408
|
519
|
392
|
1,661
|
Other
adjustments(2)
|
|
|
|
|
119
|
Leverage
EBITDA
|
|
|
|
|
1,780
|
(1)
|
Includes the
impact of operating leases prior to the adoption of IFRS 16,
previously recognized under operating costs, which aligns with
management's view of the impact of earnings.
|
(2)
|
Includes adjustments to
normalize Adjusted EBITDA for non-recurring events relating to the
completion of turnarounds and third-party power outage.
|
Measures of Segment Profit (Loss) and Total of Segments
Measures
Adjusted earnings (loss) before interest, taxes, depreciation
and amortization ("Adjusted EBITDA") is a measure of segment profit
(loss) and its aggregate is a total of segments measure used by the
chief operating decision maker to make decisions about resource
allocation to the segment and to assess its performance. In
accordance with IFRS Accounting Standards, adjustments and
eliminations made in preparing an entity's financial statements and
allocations of revenue, expenses, and gains or losses shall be
included in determining reported segment profit (loss) only if they
are included in the measure of the segment's profit (loss) that is
used by the chief operating decision maker. As such, Parkland's
Adjusted EBITDA is unlikely to be comparable to measures of segment
profit (loss) presented by other issuers, who may calculate these
measures differently. Parkland views Adjusted EBITDA as the key
measure for the underlying core operating performance of business
segment activities at an operational level. Adjusted EBITDA is used
by management to set targets for Parkland (including annual
guidance and variable compensation targets) and is used to
determine Parkland's ability to service debt, finance capital
expenditures and provide for dividend payments to shareholders.
See Section 16 of the Q4 2024
MD&A, which is incorporated by reference into this news
release, for the detailed definition and composition of Adjusted
EBITDA. Refer to the table below for the reconciliation of Adjusted
EBITDA to net earnings (loss), which is the most directly
comparable financial measure, for the year ended December 31, 2024 and December 31, 2023.
|
Three months ended
December 31,
|
Year ended
December 31,
|
($ millions)
|
2024
|
2023
|
2024
|
2023
|
Adjusted
EBITDA
|
428
|
463
|
1,690
|
1,913
|
Less/(add):
|
|
|
|
|
Acquisition,
integration and other costs
|
81
|
42
|
218
|
146
|
Depreciation and
amortization
|
210
|
222
|
825
|
823
|
Finance
costs
|
92
|
89
|
378
|
384
|
(Gain) loss on foreign
exchange – unrealized
|
(2)
|
—
|
6
|
35
|
(Gain) loss on risk
management and other – unrealized
|
34
|
28
|
45
|
(34)
|
Other (gains) and
losses(1)
|
30
|
5
|
38
|
3
|
Other adjusting
items(2)
|
20
|
6
|
53
|
48
|
Income tax expense
(recovery)
|
(8)
|
(15)
|
—
|
37
|
Net earnings
(loss)
|
(29)
|
86
|
127
|
471
|
(1)
|
Other (gains) and
losses for the three months ended December 31, 2024, include: (i)
$45 million non-cash valuation loss (2023 - $14 million gain) due
to change in fair value of redemption options; (ii) $10 million
gain (2023 - $15 million) on disposal of assets; (iii) $5 million
non-cash valuation gain (2023 - $11 million loss) due to the change
in estimates of environmental provisions; (iv) $2 million (2023 -
$2 million) in other income; (v) $2 million loss (2023 - $21
million) in others; and (vi) nil non-cash valuation loss (2023 - $4
million) due to impairments and write-offs. Other (gains) and
losses for the year ended December 31, 2024, include: (i) $44
million non-cash valuation loss (2023 - $31 million gain) due
to the change in fair value of redemption options; (ii) $37 million
non-cash valuation loss (2023 - $41 million) due to impairments and
write-offs; (iii) $16 million non-cash valuation gain (2023 -
$14 million loss) due to the change in estimates of environmental
provisions; (iv) $15 million gain (2023 - $14 million gain) on
disposal of assets; (v) $10 million (2023 - $23 million) in other
income; and (vi) $2 million gain (2023 - $16 million loss) in
others. Refer to Note 22 of the 2024 Annual Consolidated Financial
Statements.
|
(2)
|
Other adjusting items
for the three months ended December 31, 2024, include: (i) the
share of depreciation, income taxes and other adjustments for
investments in joint ventures and associates of $18 million (2023 -
$9 million); (ii) the impact of hyperinflation accounting of $4
million (2023 - $2 million); (iii) other income of $1 million (2023
- $2 million); (iv) realized gains and losses on risk management
and other assets and liabilities related to underlying physical
sales activity in another period of $1 million gain (2023 - $2
million); (v) adjustment to foreign exchange losses related to cash
pooling arrangements of $1 million gain (2023 - $1 million); and
(vi) adjustment to realized risk management gains related to
interest rate swaps, as these gains do not relate to commodity sale
and purchase transactions, of $1 million (2023 - nil). Other
adjusting items for the year ended December 31, 2024, include: (i)
the share of depreciation, income taxes and other adjustments for
investments in joint ventures and associates of $29 million (2023 -
$20 million); (ii) realized gains and losses on risk management and
other assets and liabilities related to underlying physical sales
activity in another period of $11 million loss (2023 - $6 million
gain); (iii) other income of $9 million (2023 -
$23 million); (iv) the impact of hyperinflation accounting of
$4 million (2023 - $2 million); (v) adjustment to foreign
exchange losses related to cash pooling arrangements of $3 million
(2023 - nil); (vi) adjustment to realized risk management
gains related to interest rate swaps, as these gains do not relate
to commodity sale and purchase transactions, of $3 million (2023 -
nil); and (vii) the effect of market-based performance conditions
for equity-settled share-based award settlements of nil (2023 - $13
million).
|
Supplementary Financial Measures
Parkland uses a number of supplementary financial measures,
including Liquidity available and TTM Cash generated from (used in)
operating activities per share, to evaluate the success of our
strategic objectives and to set variable compensation targets for
employees. These measures may not be comparable to similar measures
presented by other issuers, as other issuers may calculate these
measures differently. See Section 16
of the Q4 2024 MD&A, which is incorporated by reference into
this news release, for further details regarding supplementary
financial measures used by Parkland, including the composition of
such measures.
Non-Financial Measures
Parkland uses a number of non-financial measures, including
Company SSVG, composite utilization and total recordable
injury frequency rate, to measure the success of our strategic
objectives and to set variable compensation targets for employees.
These non-financial measures are not accounting measures, do not
have comparable IFRS Accounting Standards measures, and may not be
comparable to similar measures presented by other issuers, as other
issuers may calculate these metrics differently. See Section 16 of the Q4 2024 MD&A, which is
incorporated by reference into this news release, for further
details on the non-financial measures used by Parkland.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/parkland-reports-fourth-quarter-and-year-end-2024-results-initiates-review-of-strategic-alternatives-302393768.html
SOURCE Parkland Corporation